Publications by authors named "Stephane Minvielle"

56Publications

The effects of MicroRNA deregulation on pre-RNA processing network in multiple myeloma.

Leukemia 2020 01 10;34(1):167-179. Epub 2019 Jun 10.

Jerome Lipper Multiple Myeloma Disease Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-019-0498-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901818PMC
January 2020

Constraints on signaling network logic reveal functional subgraphs on Multiple Myeloma OMIC data.

BMC Syst Biol 2018 03 21;12(Suppl 3):32. Epub 2018 Mar 21.

LS2N, UMR 6004, École Centrale de Nantes, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12918-018-0551-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872385PMC
March 2018

Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome.

J Clin Oncol 2016 06 25;34(18):2125-32. Epub 2016 Apr 25.

Bruno Royer, Momar Diouf, and Jean Pierre Marolleau, University Hospital, Amiens; Stéphane Minvielle and Philippe Moreau, University Hospital; Stéphane Minvielle, Institut National de la Santé et de la Recherche Médicale U892, Nantes; Murielle Roussel and Hervé Avet-Loiseau, Institute Universitaire du Cancer de Toulouse Oncopole; Hervé Avet-Loiseau, University Hospital, Toulouse; Lionel Karlin, University Hospital, Lyon; Cyrille Hulin, University Hospital, Vandœuvre lès Nancy; Bertrand Arnulf, St Louis University Hospital; Laurent Frenzel, Necker University Hospital; Laurent Garderet, St Antoine University Hospital; Sylvain Choquet, La Pitié University Hospital, Paris; Margaret Macro, University Hospital, Caen; Sylvie Cailleres, General Hospital, Aix en Provence; Annie Brion, University Hospital, Besançon; Sabine Brechignac, University Hospital, Bobigny; Karim Belhadj, University Hospital, Creteil; Marie Lorraine Chretien, University Hospital, Dijon; Marc Wetterwald, General Hospital, Dunkerque; Carine Chaleteix, University Hospital, Clermont-Ferrand; Mourad Tiab, General Hospital, La Roche/Yon; Xavier Leleu, University Hospital, Poitiers; Jean Gabriel Fuzibet, University Department, Nice; Charles Dauriac, University Hospital, Rennes; Luc-Matthieu Forneker, University Hospital, Strasbourg; Lotfi Benboubker, University Hospital, Tours; and Thierry Facon, University Hospital, Lille, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.1929DOI Listing
June 2016

MB4-2 breakpoint in MMSET combined with del(17p) defines a subset of t(4;14) multiple myeloma with very poor prognosis.

Haematologica 2015 Nov 23;100(11):e471-4. Epub 2015 Jul 23.

Immuno-Hematology, Saint-Louis Hospital, Paris, France Université Paris Diderot, Sorbonne Paris Cité, Paris, France INSERM UMR 1126 Institut Universitaire d'Hématologie, Paris, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2015.127001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825293PMC
November 2015

Differential and limited expression of mutant alleles in multiple myeloma.

Blood 2014 Nov 18;124(20):3110-7. Epub 2014 Sep 18.

Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; Department of Hematology/Oncology, Boston Veterans Administration Healthcare System, West Roxbury, MA;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2014-04-569327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231420PMC
November 2014

The shaping and functional consequences of the dosage effect landscape in multiple myeloma.

BMC Genomics 2013 Oct 2;14:672. Epub 2013 Oct 2.

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-14-672DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907079PMC
October 2013

Identification of human leucocyte antigen (HLA)-A*0201-restricted cytotoxic T lymphocyte epitopes derived from HLA-DOβ as a novel target for multiple myeloma.

Br J Haematol 2013 Nov 30;163(3):343-51. Epub 2013 Aug 30.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Cancer Vaccine Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Department of Biomedical Science, Jungwon University, Chungcheongbuk-do, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12544DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137325PMC
November 2013

Cereblon expression in multiple myeloma: not ready for prime time.

Br J Haematol 2013 Oct 17;163(2):282-4. Epub 2013 Jul 17.

Haematology Laboratory, University Hospital, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.12478DOI Listing
October 2013

Molecular heterogeneity of multiple myeloma: pathogenesis, prognosis, and therapeutic implications.

J Clin Oncol 2011 May 11;29(14):1893-7. Epub 2011 Apr 11.

University Hospital, Institut National de la Santé et de la Recherche Médicale U892, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.32.8435DOI Listing
May 2011

The dChip survival analysis module for microarray data.

BMC Bioinformatics 2011 Mar 9;12:72. Epub 2011 Mar 9.

Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard School of Public Health, 450 Brookline Ave, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2105-12-72DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068974PMC
March 2011

Pathway-based identification of SNPs predictive of survival.

Eur J Hum Genet 2011 Jun 2;19(6):704-9. Epub 2011 Feb 2.

Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ejhg.2011.3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110054PMC
June 2011

Prognostic significance of copy-number alterations in multiple myeloma.

J Clin Oncol 2009 Sep 17;27(27):4585-90. Epub 2009 Aug 17.

L'Institut National de la Santé et de la Recherche Médicale U892, Université de Nantes, Institut de Biologie, 9 Quai Moncousu, Nantes, 44093, France.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2008.20.6136
Publisher Site
http://dx.doi.org/10.1200/JCO.2008.20.6136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2754906PMC
September 2009

Prediction of metastatic relapse in node-positive breast cancer: establishment of a clinicogenomic model after FEC100 adjuvant regimen.

Breast Cancer Res Treat 2008 Jun 21;109(3):491-501. Epub 2007 Jul 21.

Service d'Oncologie Médicale, Centre de Lutte Contre le Cancer René Gauducheau, Bd J. Monod, 44805, Nantes-Saint Herblain Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-007-9673-xDOI Listing
June 2008

Gene Expression Profiles Discriminate between Pathological Complete Response and Resistance to Neoadjuvant FEC100 in Breast Cancer.

Cancer Genomics Proteomics 2006 Mar-Apr;3(2):89-95. Epub 2006 Mar 1.

Département de Biologie Oncologique, Centre de Lutte Contre le Cancer René Gauducheau, Bd J. Monod, 44805 Nantes - Saint Herblain Cedex

View Article

Download full-text PDF

Source
March 2006

[Gene expression profiling of multiple myeloma].

Bull Cancer 2003 Feb;90(2):127-30

Inserm U463, Institut de Biologie, 9, quai Moncousu, 44035 Nantes Cedex.

View Article

Download full-text PDF

Source
February 2003